Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The American Journal of Cardiology|August 21, 2010
Effect of candesartan treatment on left ventricular remodeling after aortic valve replacement for aortic stenosisJordi S Dahl, Lars Videbaek, Mikael K Poulsen, et al.
European Journal of Heart Failure|June 17, 2008
Effect of repeated intracoronary injection of bone marrow cells in patients with ischaemic heart failure the Danish stem cell study--congestive heart failure trial (DanCell-CHF)Axel C P Diederichsen, Jacob E Møller, Per Thayssen, et al.
European Journal of Heart Failure|January 12, 2016
Incidence of cancer in patients with chronic heart failure: a long-term follow-up studyAnn Banke, Morten Schou, Lars Videbaek, et al.
Diabetes, Obesity & Metabolism|July 7, 2020
The impact of the glucagon-like peptide-1 receptor agonist liraglutide on natriuretic peptides in heart failure patients with reduced ejection fraction with and without type 2 diabetesRoni Nielsen, Anders Jorsal, Rasmus S Tougaard, et al.
European Heart Journal|August 10, 2012
Extended heart failure clinic follow-up in low-risk patients: a randomized clinical trial (NorthStar)Morten Schou, Finn Gustafsson, Lars Videbaek, et al.
Scandinavian Cardiovascular Journal : SCJ|April 16, 2020
Heart rate increases in liraglutide treated chronic heart failure patients: association with clinical parameters and adverse eventsRasmus Stilling Tougaard, Anders Jorsal, Lise Tarnow, et al.
Circulation. Heart Failure|October 22, 2013
Incidence and predictors of end-stage renal disease in outpatients with systolic heart failureHelle Bosselmann, Gunnar Gislason, Finn Gustafsson, et al.
International Journal of Cardiology. Heart & Vasculature|September 4, 2024
Excess long-term risk of adverse outcomes in heart failure patients with high and low levels of NT-proBNP: A 7-year follow-up study (NorthStar Trial)Anna Tuxen, Morten Malmborg, Nina Nouravesh, et al.
European Journal of Heart Failure|March 20, 2013
Adding serial N-terminal pro brain natriuretic peptide measurements to optimal clinical management in outpatients with systolic heart failure: a multicentre randomized clinical trial (NorthStar monitoring study)Morten Schou, Finn Gustafsson, Lars Videbaek, et al.
ESC Heart Failure|February 2, 2022
Effect of implantable cardioverter-defibrillators in patients with non-ischaemic systolic heart failure and concurrent coronary atherosclerosisChristina Byrne, Ole Ahlehoff, Marie Bayer Elming, et al.
Pageof 3